{"transactions":[{"id":2359671,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Dev. Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-02T20:34:13.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on February 28, 2022 pursuant to the Plan.  The shares underlying this option vest as to 25% of the shares on February 28, 2023, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":90000,"derivative":{"exercise_price":10.33,"expiration_date":"2032-02-27","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-22-014629","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919122014629/doc4.xml","form_type":"4"}},{"id":2359670,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Dev. Officer"}}],"security":"Common Stock","published_at":"2022-03-02T20:34:13.000Z","date":"2022-02-28","kind":"sale","acquired":false,"shares":1663,"price":10.2376,"value":17025.1288,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price.  These shares were sold in multiple transactions at prices ranging from $10.24 to $10.41, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":168290,"source":{"system":"sec-edgar","filing":"0001209191-22-014629","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919122014629/doc4.xml","form_type":"4"}},{"id":2359669,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Dev. Officer"}}],"security":"Common Stock","published_at":"2022-03-02T20:34:13.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":68250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted stock units (\"RSUs\") pursuant to the Karyopharm Therapeutics Inc. 2013 Stock Incentive Plan (the \"Plan\").  RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis.  The RSUs vest in four equal annual installments beginning February 28, 2023."}],"balance_after":169953,"source":{"system":"sec-edgar","filing":"0001209191-22-014629","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919122014629/doc4.xml","form_type":"4"}},{"id":2381697,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Dev. Officer"}}],"security":"Common Stock","published_at":"2022-02-22T21:16:24.000Z","date":"2022-02-17","kind":"sale","acquired":false,"shares":2929,"price":12.1234,"value":35509.4386,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 17, 2022 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees."}],"balance_after":101703,"source":{"system":"sec-edgar","filing":"0001209191-22-011643","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919122011643/doc4.xml","form_type":"4"}},{"id":2406010,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Dev. Officer"}}],"security":"Common Stock","published_at":"2022-02-09T22:26:46.000Z","date":"2022-02-07","kind":"sale","acquired":false,"shares":1991,"price":9.862,"value":19635.242,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 7, 2022 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 861 shares and 1,323 shares acquired under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan on April 30, 2021 and October 31, 2021, respectively."}],"balance_after":104632,"source":{"system":"sec-edgar","filing":"0001209191-22-008128","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919122008128/doc4.xml","form_type":"4"}},{"id":2825514,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Dev. Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-02T01:12:09.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":59968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on February 25, 2021 pursuant to the Plan.  The shares underlying this option vest as to 25% of the shares on February 25, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":59968,"derivative":{"exercise_price":14.56,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":59968},"source":{"system":"sec-edgar","filing":"0001209191-21-015484","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919121015484/doc4.xml","form_type":"4"}},{"id":2825513,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Dev. Officer"}}],"security":"Common Stock","published_at":"2021-03-02T01:12:09.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":22013,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of Restricted Stock Units (\"RSUs\") pursuant to the Karyopharm Therapeutics Inc. 2013 Stock Incentive Plan (the \"Plan\"). RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in four equal annual installments beginning February 25, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person has reported prior awards of RSUs in Table II of Form 4. The total reported in Column 5 includes the 22,013 newly awarded RSUs, 36,300 RSUs previously reported in Table II, and 46,126 shares of common stock."}],"balance_after":104439,"source":{"system":"sec-edgar","filing":"0001209191-21-015484","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919121015484/doc4.xml","form_type":"4"}},{"id":2842776,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Dev. Officer"}}],"security":"Common Stock","published_at":"2021-02-23T01:11:55.000Z","date":"2021-02-18","kind":"sale","acquired":false,"shares":2887,"price":14.8312,"value":42817.6744,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 18, 2021 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees."}],"balance_after":46126,"source":{"system":"sec-edgar","filing":"0001209191-21-012967","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919121012967/doc4.xml","form_type":"4"}},{"id":2853595,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Dev. Officer"}}],"security":"Restricted Stock Units","published_at":"2021-02-17T23:47:28.000Z","date":"2021-02-15","kind":"exercise","acquired":false,"shares":9675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 15, 2019, the reporting person was granted 38,700 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.  25% of the restricted stock units vested on February 15, 2021.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 15, 2019, the reporting person was granted 38,700 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.  25% of the restricted stock units vested on February 15, 2021.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date."}],"balance_after":19350,"derivative":{"underlying":"Common Stock","underlying_shares":9675},"source":{"system":"sec-edgar","filing":"0001209191-21-011490","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919121011490/doc4.xml","form_type":"4"}},{"id":2853594,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Dev. Officer"}}],"security":"Common Stock","published_at":"2021-02-17T23:47:28.000Z","date":"2021-02-15","kind":"exercise","acquired":true,"shares":9675,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis."}],"balance_after":49013,"source":{"system":"sec-edgar","filing":"0001209191-21-011490","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919121011490/doc4.xml","form_type":"4"}},{"id":2853593,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Dev. Officer"}}],"security":"Common Stock","published_at":"2021-02-17T23:47:28.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":2046,"price":15.519,"value":31751.874,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 11, 2021 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees."}],"balance_after":39338,"source":{"system":"sec-edgar","filing":"0001209191-21-011490","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919121011490/doc4.xml","form_type":"4"}},{"id":2871314,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Dev. Officer"}}],"security":"Restricted Stock Units","published_at":"2021-02-10T01:33:50.000Z","date":"2021-02-05","kind":"exercise","acquired":false,"shares":5650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 5, 2020, the reporting person was granted 22,600 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.  25% of the restricted stock units vested on February 5, 2021.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 5, 2020, the reporting person was granted 22,600 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.  25% of the restricted stock units vested on February 5, 2021.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date."}],"balance_after":16950,"derivative":{"underlying":"Common Stock","underlying_shares":5650},"source":{"system":"sec-edgar","filing":"0001209191-21-009079","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919121009079/doc4.xml","form_type":"4"}},{"id":2871313,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Dev. Officer"}}],"security":"Common Stock","published_at":"2021-02-10T01:33:50.000Z","date":"2021-02-05","kind":"exercise","acquired":true,"shares":5650,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 646 shares acquired under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan on October 31, 2020."}],"balance_after":41384,"source":{"system":"sec-edgar","filing":"0001209191-21-009079","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919121009079/doc4.xml","form_type":"4"}},{"id":3154049,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Dev Operations Officer"}}],"security":"Common Stock","published_at":"2020-05-11T20:26:33.000Z","date":"2020-05-07","kind":"sale","acquired":false,"shares":1974,"price":20,"value":39480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 996 shares acquired under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan."}],"balance_after":35088,"source":{"system":"sec-edgar","filing":"0001209191-20-028271","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120028271/doc4.xml","form_type":"4"}},{"id":3255873,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Dev Operations Officer"}}],"security":"Common Stock","published_at":"2020-02-21T22:57:28.000Z","date":"2020-02-19","kind":"sale","acquired":false,"shares":2975,"price":16.4819,"value":49033.6525,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 19, 2020 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees."}],"balance_after":36066,"source":{"system":"sec-edgar","filing":"0001209191-20-011696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120011696/doc4.xml","form_type":"4"}},{"id":3262331,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Dev Operations Officer"}}],"security":"Restricted Stock Units","published_at":"2020-02-19T23:12:00.000Z","date":"2020-02-15","kind":"exercise","acquired":false,"shares":9675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 15, 2019, the reporting person was granted 38,700 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.  25% of the restricted stock units vested on February 15, 2020.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any an event within 30 days of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 15, 2019, the reporting person was granted 38,700 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.  25% of the restricted stock units vested on February 15, 2020.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any an event within 30 days of such date."}],"balance_after":29025,"derivative":{"underlying":"Common Stock","underlying_shares":9675},"source":{"system":"sec-edgar","filing":"0001209191-20-010756","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120010756/doc4.xml","form_type":"4"}},{"id":3262330,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Dev Operations Officer"}}],"security":"Common Stock","published_at":"2020-02-19T23:12:00.000Z","date":"2020-02-15","kind":"exercise","acquired":true,"shares":9675,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,633 shares acquired under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan."}],"balance_after":39041,"source":{"system":"sec-edgar","filing":"0001209191-20-010756","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120010756/doc4.xml","form_type":"4"}},{"id":3284078,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Dev Operations Officer"}}],"security":"Restricted Stock Units","published_at":"2020-02-07T21:19:39.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":22600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Karyopharm Therapeutics Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 5, 2021, the first anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following each vesting date, but in any event within 30 days of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 5, 2021, the first anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following each vesting date, but in any event within 30 days of such date."}],"balance_after":22600,"derivative":{"underlying":"Common Stock","underlying_shares":22600},"source":{"system":"sec-edgar","filing":"0001209191-20-007510","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120007510/doc4.xml","form_type":"4"}},{"id":3284077,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Dev Operations Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-07T21:19:39.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":60600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 5, 2020.  The shares underlying this option vest as to 25% of the shares on February 5, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":60600,"derivative":{"exercise_price":18,"expiration_date":"2030-02-04","underlying":"Common Stock","underlying_shares":60600},"source":{"system":"sec-edgar","filing":"0001209191-20-007510","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120007510/doc4.xml","form_type":"4"}},{"id":3649080,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Dev Operations Officer"}}],"security":"Restricted Stock Units","published_at":"2019-02-19T21:27:45.000Z","date":"2019-02-15","kind":"grant","acquired":true,"shares":38700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Karyopharm Therapeutics Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 15, 2020, the first anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following each vesting date, but in any event within 30 days of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 15, 2020, the first anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following each vesting date, but in any event within 30 days of such date."}],"balance_after":38700,"derivative":{"underlying":"Common Stock","underlying_shares":38700},"source":{"system":"sec-edgar","filing":"0001209191-19-011082","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919119011082/doc4.xml","form_type":"4"}},{"id":3649079,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Dev Operations Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-19T21:27:45.000Z","date":"2019-02-15","kind":"grant","acquired":true,"shares":102800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 15, 2019. The shares underlying this option vest as to 25% of the shares on February 15, 2020, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":102800,"derivative":{"exercise_price":9.21,"expiration_date":"2029-02-14","underlying":"Common Stock","underlying_shares":102800},"source":{"system":"sec-edgar","filing":"0001209191-19-011082","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919119011082/doc4.xml","form_type":"4"}},{"id":4089512,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Dev Operations Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-25T21:31:36.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 24, 2018.  The shares underlying this option vest as to 25% of the shares on January 24, 2019, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":60000,"derivative":{"exercise_price":10.45,"expiration_date":"2028-01-23","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001209191-18-005383","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919118005383/doc4.xml","form_type":"4"}},{"id":4167249,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Dev Operations Officer"}}],"security":"Common Stock","published_at":"2017-11-09T21:04:52.000Z","date":"2017-11-07","kind":"sale","acquired":false,"shares":4958,"price":11.2455,"value":55755.189,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 6, 2017 and November 7, 2017 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees."}],"balance_after":24733,"source":{"system":"sec-edgar","filing":"0001209191-17-059945","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919117059945/doc4.xml","form_type":"4"}},{"id":4171131,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Dev Operations Officer"}}],"security":"Restricted Stock Units","published_at":"2017-11-06T21:09:12.000Z","date":"2017-11-05","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Karyopharm Therapeutics Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On November 5, 2015, the reporting person was granted 30,000 restricted stock units.  50% of the restricted stock units vested on November 5, 2016.  The remaining 50% of the restricted stock units vested on November 5, 2017.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On November 5, 2015, the reporting person was granted 30,000 restricted stock units.  50% of the restricted stock units vested on November 5, 2016.  The remaining 50% of the restricted stock units vested on November 5, 2017.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-17-059399","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919117059399/doc4.xml","form_type":"4"}},{"id":4171130,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Dev Operations Officer"}}],"security":"Common Stock","published_at":"2017-11-06T21:09:12.000Z","date":"2017-11-05","kind":"exercise","acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Karyopharm Therapeutics Inc. common stock."}],"balance_after":29691,"source":{"system":"sec-edgar","filing":"0001209191-17-059399","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919117059399/doc4.xml","form_type":"4"}},{"id":4482776,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Dev Operations Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-24T22:39:45.000Z","date":"2017-01-20","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on January 20, 2017.  The shares underlying this option vest as to 25% of the shares on January 20, 2018, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":100000,"derivative":{"exercise_price":10.39,"expiration_date":"2027-01-19","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-17-005327","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919117005327/doc4.xml","form_type":"4"}},{"id":4554617,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Dev Operations Officer"}}],"security":"Common Stock","published_at":"2016-11-15T21:05:21.000Z","date":"2016-11-14","kind":"sale","acquired":false,"shares":3309,"price":10.0593,"value":33286.2237,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $10.05 to $10.13, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":14691,"source":{"system":"sec-edgar","filing":"0001209191-16-150139","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919116150139/doc4.xml","form_type":"4"}},{"id":4563614,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Dev Operations Officer"}}],"security":"Restricted Stock Units","published_at":"2016-11-08T21:13:07.000Z","date":"2016-11-05","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Karyopharm Therapeutics Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On November 5, 2015, the reporting person was granted 30,000 restricted stock units. 50% of the restricted stock units vested on November 5, 2016, and the remaining 50% of the restricted stock units will vest on November 5, 2017.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On November 5, 2015, the reporting person was granted 30,000 restricted stock units. 50% of the restricted stock units vested on November 5, 2016, and the remaining 50% of the restricted stock units will vest on November 5, 2017.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date."}],"balance_after":15000,"derivative":{"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-16-148848","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919116148848/doc4.xml","form_type":"4"}},{"id":4563613,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":129718,"kind":"person","name":"Frenkel Ran","position":1,"cik":"0001623108","reported_name":"Frenkel Ran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Dev Operations Officer"}}],"security":"Common Stock","published_at":"2016-11-08T21:13:07.000Z","date":"2016-11-05","kind":"exercise","acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Karyopharm Therapeutics Inc. common stock."}],"balance_after":18000,"source":{"system":"sec-edgar","filing":"0001209191-16-148848","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919116148848/doc4.xml","form_type":"4"}}]}